Comparison of fibrin clots derived from peripheral blood and bone marrow

Connect Tissue Res. 2017 Mar;58(2):208-214. doi: 10.1080/03008207.2016.1215443. Epub 2016 Jul 27.

Abstract

Background: Autologous fibrin clots derived from peripheral blood (pb-fibrin clot) and bone marrow (bm-fibrin clot) are thought to be effective for tissue regeneration. However, there is no report detailing the amount of growth factors in pb-/bm-fibrin clot. In this study we evaluated the amount of growth factors in human pb-/bm-fibrin clot, and prove the validity of fibrin clot for clinical use.

Methods: Human pb-/bm-fibrin clots were obtained during surgery. In the first experiment, enzyme-linked immunosorbent assay (ELISA) was performed for detecting the amount of vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), fibroblast growth factor basic (bFGF), hepatocyte growth factor (HGF), transforming growth factor-beta (TGF-β), platelet derived-growth factors-AB (PDGF-AB), and stromal cell-derived factor-1 (SDF-1). In the second experiment, the efficacy of fibrin clot on the osteogenic differentiation and fibroblast proliferation was evaluated. Pb-/bm-fibrin clots were incubated in human osteoblast derived from mesenchymal stromal cells (MSCs) or human skin fibroblast. Alizarin red staining and real-time PCR (COL1A1, RUNX2) were performed for the detection of osteogenic potential. Cell-growth assay (WST-8) and real-time PCR (COL1A1) were also performed for the detection of the potential of fibroblast proliferation.

Results: ELISA analysis revealed that the amount of VEGF, HGF, bFGF, IGF-1, and SDF-1 of bm-fibrin clot group is higher than that of pb-fibrin clot group with statistical differences. Besides, we confirmed that bm-fibrin clot has much potential for the osteogenic differentiation and fibroblast proliferation.

Conclusion: The positive outcomes confirm the efficacy of pb-/bm-fibrin clot, and bm-fibrin clot was proved to have much potential for tissue regeneration compared with pb-fibrin clot. The current study showed the potential of a strategy for regenerative medicine using bm-fibrin clot.

Keywords: Bone marrow; fibrin clot; fibroblast proliferation; growth factor; osteogenic differentiation.

MeSH terms

  • Adult
  • Aged
  • Bone Marrow / metabolism*
  • Collagen Type I / biosynthesis*
  • Collagen Type I, alpha 1 Chain
  • Core Binding Factor Alpha 1 Subunit / biosynthesis*
  • Female
  • Fibrin / metabolism*
  • Fibrinolysis / physiology*
  • Humans
  • Intercellular Signaling Peptides and Proteins / biosynthesis*
  • Male
  • Middle Aged
  • Organ Specificity / physiology

Substances

  • Collagen Type I
  • Collagen Type I, alpha 1 Chain
  • Core Binding Factor Alpha 1 Subunit
  • Intercellular Signaling Peptides and Proteins
  • RUNX2 protein, human
  • Fibrin